Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Curing Hematological Diseases

  • Post author:
  • Post published:May 24, 2026
  • Post category:

The primary aim of this project is to develop treatments for incurable diseases of the blood and immune system. X-linked Severe Combined Immunodeficiency (X-SCID) and Fanconi anemia (FA) are two…

Continue ReadingCuring Hematological Diseases

Human Immune System Mouse models as preclinical platforms for stem cell derived grafts

  • Post author:
  • Post published:May 24, 2026
  • Post category:

A major obstacle to stem cell based therapies is the immune response of the patient to stem cell derived tissue, which can be recognized as foreign and attacked by the…

Continue ReadingHuman Immune System Mouse models as preclinical platforms for stem cell derived grafts

Role of Innate Immunity in hematopoeitic stem cell-mediated allograft tolerance

  • Post author:
  • Post published:May 24, 2026
  • Post category:

The research proposed in this project has very high potential to identify new medications to boost the natural ability of stem cells to prevent rejection of transplanted organs. This is…

Continue ReadingRole of Innate Immunity in hematopoeitic stem cell-mediated allograft tolerance

Engineered immune tolerance by Stem Cell-derived thymic regeneration

  • Post author:
  • Post published:May 24, 2026
  • Post category:

Stem cell therapies have the potential to transform medicine by allowing the regeneration of tissues or organs damaged by disease or trauma. In order for stem cell therapies to proceed,…

Continue ReadingEngineered immune tolerance by Stem Cell-derived thymic regeneration

Induction of immune tolerance to human embryonic stem cell-derived allografts

  • Post author:
  • Post published:May 24, 2026
  • Post category:

Human embryonic stem cells (hESCs) can undergo unlimited reproduction and retain the capability to differentiate into all cell types in the body. Therefore, as a renewable source of various cell…

Continue ReadingInduction of immune tolerance to human embryonic stem cell-derived allografts

Engineering Thymic Regeneration to Induce Tolerance

  • Post author:
  • Post published:May 24, 2026
  • Post category:

A healthy immune system produces T cells that can recognize and react against foreign molecules (antigens) to protect against infection, while leaving normal host cells with “self antigens” undamaged. All…

Continue ReadingEngineering Thymic Regeneration to Induce Tolerance

Application of Tolerogenic Dendritic Cells for Hematopoietic Stem Cell Transplantation

  • Post author:
  • Post published:May 24, 2026
  • Post category:

The immune system protects us from invading pathogens, but has to be kept in check to prevent harmful responses to our own tissues. Unique immune “suppressor” cells have been recently…

Continue ReadingApplication of Tolerogenic Dendritic Cells for Hematopoietic Stem Cell Transplantation

Generation of regulatory T cells by reprogramming

  • Post author:
  • Post published:May 24, 2026
  • Post category:

The goal of our research is to develop efficient methods for making a particular class of immune-system cells known as regulatory T cells (Tregs). Tregs have the potential to be…

Continue ReadingGeneration of regulatory T cells by reprogramming

Maternal and Fetal Immune Responses to In Utero Hematopoietic Stem Cell Transplantation

  • Post author:
  • Post published:May 24, 2026
  • Post category:

The immune system is the body’s defense system against disease and can recognize foreign cells. Because of this, stem cells and organs that are transplanted from one person to another…

Continue ReadingMaternal and Fetal Immune Responses to In Utero Hematopoietic Stem Cell Transplantation

Thymus based tolerance to stem cell therapies

  • Post author:
  • Post published:May 24, 2026
  • Post category:

This proposal focuses on the role of the immune system in transplantation of derivatives of human pluripotent stem cells (hPSCs). A critical roadblock to successful cell replacement therapies, no matter…

Continue ReadingThymus based tolerance to stem cell therapies
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us